enVVeno Medical Ratios (2017-2020) | NVNO

Ratios Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020
Profitability
Gross Margin (Quarter) 100.00%-376.83%44.05%100.00%100.00%100.00%100.00%
EBT Margin (Quarter) -3,174.60%-6,499.91%-1,101.34%-4,688.35%-3,732.81%-3,570.75%-5,905.47%-5,064.63%
EBIT Margin (Quarter) -3,174.60%-6,499.91%-1,101.34%-4,688.35%-3,732.81%-3,570.75%-5,905.47%-5,064.63%
EBITDA Margin (Quarter) -3,174.60%-6,499.91%-1,101.34%-4,688.35%-3,732.81%-3,570.75%-5,905.47%-5,064.63%
Operating Margin (Quarter) -3,174.60%-6,499.91%-1,101.34%-4,688.35%-3,732.81%-3,570.75%-5,905.47%-5,064.63%
Net Margin (Quarter) -3,512.09%-8,506.33%-1,857.18%-15,698.14%-9,868.01%-3,523.99%-5,848.74%-5,037.05%
FCF Margin (Quarter) -4,337.59%-730.85%-5,232.32%-1,848.62%-4,187.65%-4,756.10%-4,786.21%
Efficiency
Assets Average (Quarter) 6.32M4.50M4.52M6.37M6.50M4.59M3.10M3.25M5.39M
Equity Average (Quarter) -13.44M-5.56M4.08M2.79M2.45M3.76M3.87M2.04M0.49M0.18M2.58M
Invested Capital (Quarter) -8.05M-15.74M4.61M3.54M2.04M2.87M4.65M3.08M0.99M0.19M0.65M4.79M
Asset Utilization Ratio (Quarter) 0.050.040.040.020.010.01
Leverage & Solvency
Debt to Equity (Quarter) -0.28-13.670.76
Debt Ratio (Quarter) 1.390.070.08
Equity Ratio (Quarter) -5.030.640.650.570.520.640.540.29-0.010.100.68
Valuation
Enterprise Value (Quarter) -0.02M-0.31M-0.08M-0.31M-5.94M-4.19M-2.74M-2.75M-4.47M-2.94M-1.31M-0.72M-1.56M-5.63M
Return Ratios
Return on Sales (Quarter) -31.75%-65.00%-11.01%-46.88%-37.33%-35.71%-59.05%-50.65%-66.06%-116.28%-245.67%
Return on Capital Employed (Quarter) -2.64%-2.97%-1.52%-1.60%-2.83%-8.95%-24.08%-2.10%
Return on Assets (Quarter) -1.26%-1.75%-1.76%-1.07%-1.10%-1.67%-2.45%-2.21%-1.35%
Return on Equity (Quarter) 0.48%1.49%-1.96%-2.82%-3.26%-1.82%-1.86%-3.77%-15.59%-40.51%-2.82%